CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-27 | Flynn James E 10% owner | Other acquisition · Cash-Settled Total Return Swap | +1 | 1 | ||
| 2018-12-26 | Flynn James E 10% owner | Other acquisition · Cash-Settled Total Return Swap | +1 | 1 | ||
| 2018-12-24 | Flynn James E 10% owner | Other acquisition · Cash-Settled Total Return Swap | +1 | 1 | ||
| 2018-12-21 | Flynn James E 10% owner | Other acquisition · Cash-Settled Total Return Swap | +1 | 1 | ||
| 2018-12-20 | Flynn James E 10% owner | Other acquisition · Cash-Settled Total Return Swap | +1 | 1 | ||
| 2018-12-19 | Flynn James E 10% owner | Other acquisition · Cash-Settled Total Return Swap | +1 | 1 | ||
| 2018-12-18 | Ruffo Frank Chief Financial Officer | Option exercise | +1,250 | 162,765 | ||
| 2018-12-18 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −356 | $6.30 | $2K | 162,409 |
| 2018-12-18 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −1,250 | 1,250 | ||
| 2018-12-18 | Walker Neal President and CEO | Option exercise | +2,925 | 910,957 | ||
| 2018-12-18 | Walker Neal President and CEO | Shares withheld for taxes | −833 | $6.30 | $5K | 910,124 |
| 2018-12-18 | Walker Neal President and CEO | Option exercise · Restricted Stock Units | −2,925 | 2,925 | ||
| 2018-12-18 | Shanler Stuart Chief Scientific Officer | Option exercise | +1,450 | 269,892 | ||
| 2018-12-18 | Shanler Stuart Chief Scientific Officer | Shares withheld for taxes | −412 | $6.30 | $3K | 269,480 |
| 2018-12-18 | Shanler Stuart Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,450 | 1,450 | ||
| 2018-12-18 | Fair Brett Chief Commercial Officer | Option exercise | +1,750 | 8,513 | ||
| 2018-12-18 | Fair Brett Chief Commercial Officer | Shares withheld for taxes | −498 | $6.30 | $3K | 8,015 |
| 2018-12-18 | Fair Brett Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,750 | 1,750 | ||
| 2018-12-18 | Powala Christopher Chief Reg & Develop Officer | Option exercise | +1,625 | 139,889 | ||
| 2018-12-18 | Powala Christopher Chief Reg & Develop Officer | Shares withheld for taxes | −446 | $6.30 | $3K | 139,443 |
Page 43 of 47 · 928 trades